Submitted:
25 January 2024
Posted:
26 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Data
2.2. Software
2.3. Asymmetrical entropy

2.4. pRR30 and pRR3.25%
2.5. Statistical analysis
3. Results
3.1. Entropy distribution
3.3. Diagnostic properties of single HRV parameters
3.4. Diagnostic values of models built using pRR30, pRR3.25% and asymmetric entropy indices
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- G. Hindricks, T. Potpara, N. Dagres, E. Arbelo, J. Bax, C. Blomström-Lundqvist, G. Boriani, M. Castella, G. Dan and P. Dilaveris, "2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the Europea," European heart journal, Vols. 42,5, pp. 373-498, 2021. [CrossRef]
- Ble M, Benito B, Cuadrado-Godia E, Pérez-Fernández S, Gómez M, Mas-Stachurska A, Tizón-Marcos H, Molina L, Martí-Almor J, Cladellas M. Left Atrium Assessment by Speckle Tracking Echocardiography in Cryptogenic Stroke: Seeking Silent Atrial Fibrillation. J Clin Med. 2021 Aug 9;10(16):3501. [CrossRef]
- Roten L, Goulouti E, Lam A, Elchinova E, Nozica N, Spirito A, Wittmer S, Branca M, Servatius H, Noti F, Seiler J, Baldinger SH, Haeberlin A, de Marchi S, Asatryan B, Rodondi N, Donzé J, Aujesky D, Tanner H, Reichlin T, Jüni P. Age and Sex Specific Prevalence of Clinical and Screen-Detected Atrial Fibrillation in Hospitalized Patients. J Clin Med. 2021 Oct 22;10(21):4871. [CrossRef]
- .
- Turagam MK, Flaker GC, Velagapudi P, Vadali S, Alpert MA. Atrial Fibrillation In Athletes: Pathophysiology, Clinical Presentation, Evaluation and Management. J Atr Fibrillation. 2015;8(4):1309. [CrossRef]
- Lin AL, Nah G, Tang JJ, Vittinghoff E, Dewland TA, Marcus GM. Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation. Eur Heart J. 2022;43(47):4933-4942. [CrossRef]
- Rizwan, A. Zoha, I. Mabrouk, H. Sabbour, A. Al-Sumaiti, A. Alomainy, M. Imran and Q. Abbasi, "A Review on the State of the Art in Atrial Fibrillation Detection Enabled by Machine Learning," IEEE Reviews in Biomedical Engineering, vol. 14, pp. 219-239, 2021. [CrossRef]
- Khan AA, Lip GYH, Shantsila A. Heart rate variability in atrial fibrillation: The balance between sympathetic and parasympathetic nervous system. Eur J Clin Invest. 2019 Nov;49(11):e13174. [CrossRef]
- Buś S, Jędrzejewski K, Guzik P. Statistical and Diagnostic Properties of pRRx Parameters in Atrial Fibrillation Detection. J Clin Med. 2022 Sep 27;11(19):5702. [CrossRef]
- Piskorski J, Guzik P. The structure of heart rate asymmetry: deceleration and acceleration runs. Physiol Meas. 2011 Aug;32(8):1011-23. [CrossRef]
- Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000 Jun 13;101(23):E215-20. [CrossRef]
- Petrutiu S, Sahakian AV, Swiryn S. Abrupt changes in fibrillatory wave characteristics at the termination of paroxysmal atrial fibrillation in humans. Europace. 2007 Jul;9(7):466-70. [CrossRef]
- Y. Mina-Paz, V. Santana-García, L. Tafur-Tascon, M. Cabrera-Hernández, A. Pliego-Carrillo and J. Reyes-Lagos, "Analysis of Short-Term Heart Rate Asymmetry in High-Performance Athletes and Non-Athletes.," Symmetry, vol. 14, no. 1229, 2022. [CrossRef]
- Sibrecht G, Piskorski J, Krauze T, Guzik P. Heart Rate Asymmetry, Its Compensation, and Heart Rate Variability in Healthy Adults during 48-h Holter ECG Recordings. J Clin Med. 2023 Feb 3;12(3):1219. [CrossRef]
- W. B. Guzik P, "Data distribution analysis – a preliminary approach to quantitative data in biomedical research.," JMS [Internet], 2023. [CrossRef]
- T. Fawcett, "An introduction to ROC analysis," Pattern Recognit. Lett., vol. 27, p. 861–874, 2006. [CrossRef]
- W. Youden, "Index for rating diagnostic tests.," Cancer, vol. 3, pp. 32–35.;2-3, 1950. [CrossRef]
- Glas, J. Lijmer, M. Prins, G. Bonsel and P. Bossuyt, " The diagnostic odds ratio: A single indicator of test performance.," J. Clin. Epidemiol., vol. 56, pp. 1129–1135, 2003. [CrossRef]
- F. Wilcoxon, "Individual Comparisons by Ranking Methods.," Biom. Bull, vol. 1, pp. 80-83., 1945. [CrossRef]
- Renshaw AA, Gould EW. Reducing false-negative and false-positive diagnoses in anatomic pathology consultation material. Arch Pathol Lab Med. 2013 Dec;137(12):1770-3. [CrossRef]
- Klinkman MS, Coyne JC, Gallo S, Schwenk TL. False positives, false negatives, and the validity of the diagnosis of major depression in primary care. Arch Fam Med. 1998 Sep-Oct;7(5):451-61. [CrossRef]
- Liu C, Oster J, Reinertsen E, Li Q, Zhao L, Nemati S, Clifford GD. A comparison of entropy approaches for AF discrimination. Physiol Meas. 2018 Jul 6;39(7):074002. [CrossRef]
- Zhao L, Liu C, Wei S, Shen Q, Zhou F, Li J. A New Entropy-Based Atrial Fibrillation Detection Method for Scanning Wearable ECG Recordings. Entropy (Basel). 2018 Nov 26;20(12):904. [CrossRef]
- Richman JS, Moorman JR. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H2039-49. [CrossRef]
- Żurek S, Grabowski W, Wojtiuk K, Szewczak D, Guzik P, Piskorski J. Relative Consistency of Sample Entropy Is Not Preserved in MIX Processes. Entropy (Basel). 2020 Jun 21;22(6):694. [CrossRef]
- Buś S, Jędrzejewski K, Guzik P. Using Minimum Redundancy Maximum Relevance Algorithm to Select Minimal Sets of Heart Rate Variability Parameters for Atrial Fibrillation Detection. J Clin Med. 2022 Jul 11;11(14):4004. [CrossRef]






| Parameter | AUC | Cutoff for AF | Accuracy | Sensitivity | Specificity | PPV | NPV | DOR |
| pRR3.25% | 0.9727 | <72.3684% | 95.75 | 99.60 | 92.25 | 92.12 | 99.60 | 2931.82 |
| pRR30 | 0.9596 | <66.8874% | 91.00 | 95.62 | 86.80 | 86.82 | 95.62 | 143.70 |
| HNR | 0.9315 | <0.1884 | 84.86 | 95.45 | 75.26 | 77.83 | 94.79 | 63.82 |
| HAR | 0.6951 | <0.7546 | 67.85 | 86.83 | 50.59 | 61.52 | 80.86 | 6.76 |
| HDR | 0.6686 | <0.7726 | 67.68 | 91.49 | 46.00 | 60.66 | 85.61 | 9.16 |
| H | 0.6186 | <2.0647 | 60.03 | 85.68 | 36.69 | 55.18 | 73.80 | 3.47 |
| Feature | AUC | Accuracy | DOR | FP+FN [%] | FP [%] | FN [%] |
| pRR3.25% | 0.972 | 0.9513 | 643.0 | 4.87 | 3.98 | 0.88 |
| pRR30 | 0.959 | 0.9277 | 233.5 | 7.23 | 5.57 | 1.65 |
| H | 0.613 | 0.6118 | 2.6 | 38.82 | 24.3 | 14.52 |
| HAR | 0.7 | 0.6536 | 3.6 | 34.64 | 16.11 | 18.53 |
| HDR | 0.67 | 0.6155 | 2.6 | 38.45 | 16.91 | 21.54 |
| HNR | 0.93 | 0.8842 | 84.5 | 11.58 | 09.03 | 2.55 |
| pRR3.25 & pRR30% | 0.978 | 0.955 | 687.1 | 4.5 | 3.57 | 0.93 |
| pRR3.25% & H | 0.986 | 0.9566 | 705.6 | 4.34 | 3.38 | 0.96 |
| pRR3.25% & HAR | 0.982 | 0.9549 | 693.0 | 4.51 | 3.59 | 0.92 |
| pRR3.25% & HDR | 0.977 | 0.9517 | 623.3 | 4.83 | 3.9 | 0.93 |
| pRR3.25% & HNR | 0.974 | 0.9516 | 632.3 | 4.84 | 3.93 | 0.91 |
| pRR30 & H | 0.973 | 0.9327 | 252.3 | 6.73 | 05.01 | 1.72 |
| pRR30 & HAR | 0.969 | 0.9312 | 240.5 | 6.88 | 5.13 | 1.76 |
| pRR30 & HDR | 0.963 | 0.9279 | 235.8 | 7.21 | 5.57 | 1.64 |
| pRR30 & HNR | 0.96 | 0.9284 | 232.9 | 7.16 | 5.47 | 1.69 |
| pRR30 & pRR3.25%, & H | 0.988 | 0.9577 | 695.5 | 4.23 | 3.2 | 01.03 |
| pRR30 & pRR3.25%, & HAR | 0.985 | 0.9581 | 732.4 | 4.19 | 3.22 | 0.97 |
| pRR30 & pRR3.25%, & HDR | 0.982 | 0.9541 | 633.7 | 4.59 | 3.58 | 1 |
| pRR30 & pRR3.25%, & HNR | 0.979 | 0.9537 | 631.3 | 4.63 | 3.65 | 0.99 |
| HNR & HAR, & HDR | 0.935 | 0.8838 | 82.8 | 11.62 | 09.01 | 2.61 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).